Vesna Munić Kos
Impact in
- Molecular Medicine top 10%
- Physiology top 10%
- Asthma and respiratory diseases
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Vesna Eraković HaberMartina BosnarMihailo BanjanacKrunoslav NujićMichael J. ParnhamDenis PolančecMario HlevnjakRoko Žaja
- Journals
- European Journal of Pharmacology (3 papers)Pharmacological Research (3 papers)European Journal of Pharmaceutical Sciences (3 papers)International Journal of Molecular Sciences (2 papers)British Journal of Pharmacology (2 papers)
- Partner nations
- SwedenCroatiaUnited Kingdom
In The Last Decade
Vesna Munić Kos
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Molecular Medicine 60
- Physiology 48
- Immunology 172
- Infectious Diseases 147
- Health, Toxicology and Mutagenesis 107
Countries citing papers authored by Vesna Munić Kos
This map shows the geographic impact of Vesna Munić Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesna Munić Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesna Munić Kos more than expected).
Fields of papers citing papers by Vesna Munić Kos
This network shows the impact of papers produced by Vesna Munić Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesna Munić Kos. The network helps show where Vesna Munić Kos may publish in the future.
Co-authors
The 25 scholars most cited alongside Vesna Munić Kos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2022 | 9 | |
| 5 | 2020 | 32 | |
| 6 | 2019 | 7 | |
| 7 | 2018 | 7 | |
| 8 | 2017 | 61 | |
| 9 | 2017 | 6 | |
| 10 | 2013 | 6 | |
| 11 | 2012 | 58 | |
| 12 | 2012 | 11 | |
| 13 | 2012 | 51 | |
| 14 | 2011 | 18 | |
| 15 | 2011 | 34 | |
| 16 | 2011 | 88 | |
| 17 | 2008 | 64 | |
| 18 | 2005 | 79 | |
| 19 | 2002 | 181 | |
| 20 | 2000 | 5 |
About Vesna Munić Kos
Vesna Munić Kos is a scholar working on Physiology, Pharmacology, Health, Toxicology and Mutagenesis, Immunology and Pharmacology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Immune Response and Inflammation (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Computational Drug Discovery Methods (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Sphingolipid Metabolism and Signaling (3 papers). The work is most often cited by research in Molecular Medicine (60 citations), Physiology (48 citations), Immunology (172 citations), Infectious Diseases (147 citations) and Health, Toxicology and Mutagenesis (107 citations). Vesna Munić Kos has collaborated with scholars based in Sweden, Croatia and United Kingdom. Frequent co-authors include Vesna Eraković Haber, Martina Bosnar, Mihailo Banjanac, Krunoslav Nujić, Michael J. Parnham, Denis Polančec, Mario Hlevnjak, Roko Žaja, Tvrtko Smital and Ulf Norinder. Their work appears in journals such as European Journal of Pharmacology, Pharmacological Research, European Journal of Pharmaceutical Sciences, International Journal of Molecular Sciences and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.